title: IMS-III and SYNTHESIS Expansion trials of endovascular therapy in acute ischemic stroke: how can we improve?
authors.affiliation: From the Departments of Neurology, Neurosurgery, and Radiology, Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA (R.G.N., R.G.); and Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain (A.D.).
authors.forename: Raul G
authors.initials: RG
authors.lastname: Nogueira
authors.forename: Rishi
authors.initials: R
authors.lastname: Gupta
authors.forename: Antoni
authors.initials: A
authors.lastname: Dávalos
mesh_terms: D000792:Angiography / Q000379:methods; D002986:Clinical Trials as Topic; D057510:Endovascular Procedures / Q000379:methods*; D019317:Evidence-Based Medicine; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D061185:Mechanical Thrombolysis / Q000379:methods; D018579:Patient Selection; D012107:Research Design; D020521:Stroke / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D010959:Tissue Plasminogen Activator
keywords: clinical trials; stroke; thrombectomy; tissue-type plasminogen activator